Floatz logo

CEFPODOXIME

Relapsed Solid Tumors

University of Colorado, DenverSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

0 Active assets in the Relapsed Solid Tumors cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Stanford University
Phase 1CC

Same molecule, other indications

CEFPODOXIME is also rated in:

neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →
diarrheal diseaseDormant
CC
Indicative ·
47 / 100
View asset →
Unspecified Adult Solid Tumor, Protocol SpecificDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →